武汉大学中南医院循证与医学转化中心

导航
首页 > 成果展示 > 正文

Serum mannose-binding lectin is a strong biomarker of diabetic retinopathy in chinese patients with diabetes

发布于2015-04-29 09:44:29    来自武汉大学中南医院循证与转化医学中心    人阅读
 2015 May;38(5):868-75. doi: 10.2337/dc14-1873. Epub 2015 Mar 10.

Abstract

OBJECTIVE:

Inflammation and complement activation initiated by mannose-binding lectin (MBL) may be implicated in the pathogenesis of diabetic vascular complications. We investigated serum MBL levels in patients with diabetes with and without diabetic retinopathy (DR).

RESEARCH DESIGN AND METHODS:

Serum MBL levels were determined in 348 patients with diabetes and in 100 healthy control subjects. The prediction value of MBL was compared with diabetes duration, hs-CRP, and other known predictors. Multivariate analyses were performed using logistic regression models.

RESULTS:

MBL levels on admission were significantly increased in patients with diabetes with DR (P < 0.0001) and vision-threatening DR (VTDR; P < 0.0001). Multivariate logistic regression analysis adjusted for common indictors showed that serum MBL levels ≥3,385 μg/L were an independent predictor of DR (odds ratio [OR] 3.14, 95% CI 1.77-5.57) and VTDR (OR 7.83, 95% CI 3.35-18.31). The area under the receiver operating characteristic curve of MBL was 0.81 (95% CI 0.76-0.86) for DR and 0.84 (95% CI 0.74-0.93) for VTDR.

CONCLUSIONS:

The current study demonstrated that MBL appears to be an independent biomarker for DR in the Chinese population, suggesting a possible role of MBL in the pathogenesis of DR complications in diabetes.

PMID: 25758771 [PubMed - in process]

作者团队:耿培亮,等

PUBMED网址链接:http://www.ncbi.nlm.nih.gov/pubmed/25758771

补充杂志简介:《Diabetes Care》是糖尿病研究领域的顶尖权威期刊,和Diabetes齐名。JCR分区及中科院分区皆为1区,Top期刊。2013-2014年最新影响因子:8.570

版权所有:武汉大学中南医院循证与转化医学中心
技术支持:西安渔夫网络科技有限公司
联系我们

湖北省武汉市武昌区,东湖路169号    邮编:430071

电话/传真:+86 027 67812817    邮箱:zhongnan@163.com    微博:http://weibo.com/whuznyy